Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Recurrent or Refractory Multiple Myeloma”

Showing 3 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04764942
What this trial is testing

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Mayo Clinic 39
Testing effectiveness (Phase 2)Study completedNCT00536575
What this trial is testing

Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 13
Testing effectiveness (Phase 2)Study completedNCT01794039
What this trial is testing

Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 9

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation